This is an important study that examined modifying effects of functional status on relations of BP with incident cardiovascular events in race-specific groups of the MESA cohort. This is an important area of research that builds on findings from other cohort studies and the high-risk CV population in the SPRINT clinical trial.
The methods are well done and appropriate in a large, diverse cohort. I appreciate the opportunity to participate in the review of this important work. The paper is well-written overall. A revision that clarifies the necessarily complex methodology along with rewording the translational interpretations will raise the impact of this work even further.
Introduction: 1. Some of the introductory statements (and last sentence in first paragraph of discussion are not completely accurate in the description of functional status definitions in referenced work. Although Reference #4 defined functional status as limitations in ADLs, as the authors describe, this was not true in ARIC (reference #5). ARIC included limitations in IADLs and ADLs as well as physical limitations. In addition, the ARIC reference included middle-aged and older adults although the paragraph refers only to older adults. Of note, in ARIC, functional status attenuated the relationship of SBP to mortality in middle-aged participants modestly; the effect was more pronounced among the older participants. I raise this point as it relates to comment #3 below as well. The authors may want to reword these sentences to clarify the existing research and other gaps in knowledge, e.g. need for replication, older versus middleage, racial/ethnicity effects, CV vs mortality outcomes, etc. Methods 1. Population -Please provide more description of MESA, for example, the number of participants enrolled at baseline, the number who participated in visit 2, the number who completed the functional status assessment, the number missing CV events outcomes. Were the participants with/without data different? 2. How was censoring of CV events handled? 3. MESA participants' ages span from young middle-aged to old. Age is a known modifier of the relationship of BP to mortality, a phenomenon that is not accounted for by adjusting for age. The concern here is that modifying effects of physical limitations (PL) on the SBP-CV outcomes the relationship, which are probably greater in older age, will not be adequately depicted in the current model as I understood them. This complex relationship admittedly is amplified by additionally considering race/ethnicity modification, but it is important to incorporate age as a modifier based on other studies. In ARIC, for example, SBP <120 was associated with lower incident mortality in older persons with good functional status but not among those with poor functional status. Did the authors examine an age-PL-SBP interaction term in the race-stratified models? Realizing potential for limited power in the smallest race/ethnicity groups for such models, this could be done in a very basic model with only the 3-way interaction and lower-level interaction terms in race-stratified analyses, or only additionally adjusting for sex. Since the authors hypothesize that contextual aspects of social/income influences are contained within the race variable, this basic model seems like a scientifically viable option. 4. Given Comment #3, I suggest if the authors wish to use chronologic age as a separate, crude measure of functional status to compare age versus PL as modifiers, the comparison could include the 3rd model with an age-PL-SBP interaction added to the PL model. 5. The 2-question assessment of physical limitation is a crude measure of functional status. This limitation could be included in the limitations paragraph. Did the authors compare results using selfreported walking sped or other objective functional assessment? 6. Please clarify if higher SF-12P scores represent better function 7. I found it difficult to following the description of the modeling approaches and suspect other readers would also need more carefully described analyses. After re-reading, I realized the authors defined functional status in two ways, PL and by age, and ran separate models using either of these as a functional status measure. I believe the results either show SBP-PL-race interactions (Overall results) and SBP-PL interaction within race strata, or (separately) SBP-age-race interactions (Overall) and SBP-age interaction within race strata. To arrive at this conclusion required repeated readings of the paper. The following comments are based on this understanding of the methodological approach. However, it is not clear to me if the age-SBP interaction models were adjusted for PL; the authors state all models were adjusted for age so the SBP-PL interaction models are presumably adjusted for age. The topic is complicated and is best represented with such complexity in modeling approaches, but readers would benefit from a clearer description of the analytic approach and interpretation of findings (or I just need more coffee…). 8. Related to the previous comment on methods and comment #3, I do not think it optimal to compare PL effects and age effects as both representing physical function as both are likely joint modifiers of the SBP relationship with clinical outcomes.
The authors themselves make the point that age does not characterize function well or predict outcomes, although I agree the comparison given its use in public health arenas and clinical risk scores etc. may be warranted. Including the age-PL-SBP interaction, however, is still warranted in my opinion. Again, I may have misunderstood the methods. 9. Please provide more information on spline terms in the Methods (I assume the authors are referring to splines in modeling SBP given the sentence in Results, page 10, line 44. Were clinical categories used or knots decided based on visualization using flexible modeling or on SBP quintile cut points or other? 10. It seems that if the 3-way interaction (PL-SBP-race) is significant, lack of statistical support for the 2-way interaction (PL-SBP) in race stratified models does not mean there is no interaction for a particular race group; rather, sample size and power were likely the reason for lack of statistical significance. Is there any advantage to showing results by race from the overall model containing the 3-way interaction, including estimates with imprecision of those estimates across each race group to make a determination of race differences? Perhaps this was done in the figures already; I don't expect the results would be different but might improve precision of estimates for smaller groups. Results: 1. The lowest quintile of SBP may include both healthy and ill (e.g. heart failure) participants given that the lower value is below the normal physiological levels needed to perfuse organs (generally mean arterial pressure over 60-65mmHg). Data entry or measurement errors may also explain the very low SBP number. Do the authors have information on conditions that could cause low BPs? 2. Despite the description of linear relationships, some in figure 2 do not appear linear and raises the question of whether sicker participants are in the lower SBP quintile and how the nonlinear relationships were examined. 3. Table 2 : When describing lack of modification among Hispanic and Chinese participants or in discussion, it may be worth also highlighting that these groups were a little younger, and Chinese participants had fewer PL and fewer events. Some of this was included by the authors. 4. Figures: consider showing estimates and imprecision around the estimates using confidence bars. 5. I believe Figure 1 shows 'x' and '+' marks as the estimated incidence rates for each SBP quintile by PL strata or selected age with a forced linear regression line across the SBP quintiles. Some of the estimates appear non-linear, specifically for Blacks with physical limitations or older age. Would it be more informative to show the estimates and confidence bars or bands? This would also highlight the smaller samples and greater uncertainty in the smaller groups. Confidence bars or bands could more clearly illustrate that the apparent non-linearities are not supported. The authors included a statement that "Spline models confirmed that a linear fit was appropriate…" although the details of this assessment are not clear to me. Likelihood ratios from comparative models? 6. Figure 1 : per comment #7 in Methods: are these results from analyses that were stratified by race, and included the physical limitations-SBP interaction, SBP, physical limitations and adjusted for age, sex, income (Column 1)? Column 2 is more confusing -are these results modeled using an age-SBP interaction term within race strata, adjusted for sex, income but not adjusted for PL? 7. Page 10, Results, lines 46-53 the authors state "Among white participants, the association between SBP and CVD appeared weaker among those with physical limitations compared to those without physical limitations. However, the average IRD across quintiles of SBP was slightly larger among older whites compared with younger whites." It's not clear if the difference in these numbers, 3.6 vs 2.99 per 10,000 py, is really meaningful; how was the difference in the magnitude of these estimates quantified? In addition, does this suggest the effect of increasing SBP is greater at older than younger ages, perhaps because older people are more likely to have events? Where does PL fit into this interpretation? 8. Figure 1: it might help readers if the authors also include interpretations regarding the increase in IR across quintiles by PL groups. For example, [among whites]…although those with PL had higher rates of CVD compared to those without PL, the increase across SBP quintiles was greater for those without PL" (IRD 3.35 (95%CI) 11. Recommend either including DBP results in online supplement or leave this out. Discussion: 1. The authors are appropriately cautious in interpreting results, specifically identifying the limitation of fewer numbers of Hispanics and Chinese participants compared to whites and blacks. In MESA, relationships among blacks and whites appear similar, in line with our findings from middle-aged and older adults in the ARIC population. Given these similar findings in two large studies with blacks and whites (but small representation of other race/ethnicity groups in MESA and no representation in ARIC), perhaps the discussion should be more assertive regarding the limitations in drawing conclusions about lack of findings among Hispanic and Chinese populations. I am not certain, for example, that the findings "show distinct racial/ethnic patterning". However, the findings do suggest that functional limitations may portend elevated risk in all examined racial/ethnic groups in MESA. Understanding how functional status (or factors underlying functional impairments) influence CV risk across racial/ethnic groups could be useful for identifying at-risk persons and informing public health strategies to improve health and reduce CV risk. 2. I don't understand why the authors make the statement "This pattern appeared to be consistent across both multiplicative and additive scales using self-reported physical limitations, but not age" in Discussion, 1st paragraph, and again in Discussion, 2nd paragraph "Among white participants, using self-reported physical limitations as a measure of functional status provided consistent evidence of attenuated associations between SBP and incident CVD across multiplicative and additive scales, while chronological age did not. Where feasible, physical limitations and other specific measures of functional status may be more useful than chronological age in estimating risk". a. First, are the recommendations specific to whites? This runs counter to the rationale of the study which is a focus on various racial/ethnic groups. b. Table 2 shows interaction s between PL and SBP supported in whites but not blacks although blacks had similar estimates that were not statistically supported with conventional metrics, and interactions between age and SBP were supported in both whites and blacks. Thus, PL may not work as well in blacks as in whites, yet the authors propose using PL instead of age. c. For the additive models, is the statement that age does not work as well based on the magnitude of IRDs by age in Figure 2 , which were not as large as in the PL analysis? Please clarify. 3. In discussing the associations between SBP and CVD by functional status, perhaps use less using methodological jargon (multiplicative and additive scales) and more context of how clinicians or researchers would use this information.
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GENERAL COMMENTS
Thank you for the opportunity to review your work. Please see below my comments on this article: 1. Page 2, lines 26-33. Please use the terms consistently. In this paragraph "low functional status" refers only to physical limitations, as only IRR for these groups are presented; whereas in other sections "low functional status" includes chronological age (page 9, lines 13-14). The statement starting on line 30 "We found a similar pattern …" doesn't reflect the results of physical limitations in Table  2 . Table 1 on page 14. "Average education" is not presented in Table 1 . 6. Page 9, lines 13-14. The rationale for creating "high/low functional status" category is not clear. It also adds confusion as other research defines "low functioning" differently (page 11, lines 3-7). It would seem that the terms "with/without physical limitations" and "age under/over 65" are clearer. 7. Page 10, line 39. Appendix Figure 1 is listed here, so insert this information in the pages where this figure is presented. 8. Page 10, Discussion. This first paragraph is confusing. First it is stated that there were associations between SBP and CVD among those with physical limitations and chronological age, but the next sentences states that the pattern didn't appear with age. 9. Page 11, lines 20-29. The statement that chronological age did not provide evidence of attenuated associations is not consistent with the findings reported in In addition, the ARIC reference included middle-aged and older adults although the paragraph refers only to older adults. Of note, in ARIC, functional status attenuated the relationship of SBP to mortality in middle-aged participants modestly; the effect was more pronounced among the older participants. I raise this point as it relates to comment #3 below as well. The authors may want to reword these sentences to clarify the existing research and other gaps in knowledge, e.g. need for replication, older versus middle-age, racial/ethnicity effects, CV vs mortality outcomes, etc.
Response: We revised the introduction to read: "High blood pressure (systolic blood pressure [SBP] ≥140 mmHg or diastolic blood pressure [DBP] ≥90 mmHg or taking antihypertensive medicine) is a major cause of morbidity and mortality among American adults, and is responsible for an estimated $48.6 billion in direct and indirect costs per year.1 However, the health risks associated with high blood pressure are not uniform in all adults; some subgroups have been identified in which elevated blood pressure is not associated with increased morbidity or mortality. For example, among older adults with poor functional status, measured by slow gait speed2,3 or by functional limitations, the association between high blood pressure and mortality is attenuated compared with elders with better functional status.4 Interestingly, in this latter study, the effect modification of blood pressure and mortality by functional status was less apparent in middle-aged participants. 4 There are limited data on functional status as an effect modifier of blood pressure and cardiovascular outcomes; existing studies have been limited to older adults.5,6 Thus, it is not yet clear how age and functional limitations pattern risks of CVD associated with elevated SBP." Methods 1. Population -Please provide more description of MESA, for example, the number of participants enrolled at baseline, the number who participated in visit 2, the number who completed the functional status assessment, the number missing CV events outcomes. Were the participants with/without data different?
Response: We added the following information to the first paragraph of the results section (p. 10): "Our analysis excluded 584 participants who did not have a blood pressure measurement at Exam 2, 14 participants who did not have physical function measures at Exam 2, five participants with missing information on incident CVD, and three participants who had prevalent CVD at Exam 2. Excluded participants were older (mean age 67.9 vs. 63.5), more likely to be male (61.2% vs. 47.4%), less well educated (22.7% vs. 36.7% with bachelor's or higher), had lower incomes (2.0% vs. 22.6% with income >$75,000), and were more likely to report physical limitations (50.5% vs. 27.3%). SBP, DBP, and racial/ethnic distribution were similar among excluded and included participants." The 2nd paragraph of the methods section (p. 5) includes information about participants at baseline (n=6,814).
How was censoring of CV events handled?
Response: In the Poisson models we used to estimate incidence rates, each participant is censored at the time of incident CVD, death, or loss to follow up. Please let us know if additional clarification is necessary.
3. MESA participants' ages span from young middle-aged to old. Age is a known modifier of the relationship of BP to mortality, a phenomenon that is not accounted for by adjusting for age. The concern here is that modifying effects of physical limitations (PL) on the SBP-CV outcomes the relationship, which are probably greater in older age, will not be adequately depicted in the current model as I understood them. This complex relationship admittedly is amplified by additionally considering race/ethnicity modification, but it is important to incorporate age as a modifier based on other studies. In ARIC, for example, SBP <120 was associated with lower incident mortality in older persons with good functional status but not among those with poor functional status. Did the authors examine an age-PL-SBP interaction term in the race-stratified models? Realizing potential for limited power in the smallest race/ethnicity groups for such models, this could be done in a very basic model with only the 3-way interaction and lower-level interaction terms in race-stratified analyses, or only additionally adjusting for sex. Since the authors hypothesize that contextual aspects of social/income influences are contained within the race variable, this basic model seems like a scientifically viable option.
Response: This is a good point and we ran the models among whites and African-Americans with the approach that the reviewer describes. The results of the 3-way interaction between SBP, age, and PL among whites and blacks are shown below. There are limited sample sizes in the other race/ethnicity groups (<20 events observed for 1 or more cells). Among whites, the 3-way interaction is very close to the null and not statistically significant, suggesting that there is no difference in the modifying effects of PL by age. The estimates for the 2-way interactions for age & SBP and PL * SBP remain below the null, indicating the attenuated association of SBP and CVD among older participants and those with PL. The inclusion of the 3-way interaction term rendered the 2-way interactions no longer statistically significant, but the fact that they are in the same direction supports the results in Table 2 .
In African-Americans, the 3-way interaction between SBP, age, and PL is also not statistically significant, but in this case it is above the null, suggesting the potential for synergy. However, this would be in the opposite direction of the 3-way interaction reported in ARIC. Although interesting, we are hesitant to report this because of the poor precision in the estimates. Notability, the estimates were particularly poor in Blacks in which the main effects terms were widely variable.
White ( Response: MESA has limited functional assessment variables in the early visit years. We added the limitation of using self-report physical limitation to the discussion section. We agree that the 2-question assessment of physical limitation is a crude measure of functional status, and added this to the discussion section. We selected this measure, age, and the SF-12 physical score as our a priori effect modifiers.
Please clarify if higher SF-12P scores represent better function
Response: We added the following to the description of SF-12P in the methods section (p. 6): "SF12-P scores range from 0-100 (higher scores represent better function)…" 7. I found it difficult to following the description of the modeling approaches and suspect other readers would also need more carefully described analyses. After re-reading, I realized the authors defined functional status in two ways, PL and by age, and ran separate models using either of these as a functional status measure. I believe the results either show SBP-PL-race interactions (Overall results) and SBP-PL interaction within race strata, or (separately) SBP-age-race interactions (Overall) and SBP-age interaction within race strata. To arrive at this conclusion required repeated readings of the paper. The following comments are based on this understanding of the methodological approach. However, it is not clear to me if the age-SBP interaction models were adjusted for PL; the authors state all models were adjusted for age so the SBP-PL interaction models are presumably adjusted for age. The topic is complicated and is best represented with such complexity in modeling approaches, but readers would benefit from a clearer description of the analytic approach and interpretation of findings (or I just need more coffee…).
Response: We agree that the methods section was challenging to read, even if fully caffeinated! We have rewritten the statistical methods section to be more clear -please let us know if additional changes would be helpful.
8. Related to the previous comment on methods and comment #3, I do not think it optimal to compare PL effects and age effects as both representing physical function as both are likely joint modifiers of the SBP relationship with clinical outcomes. The authors themselves make the point that age does not characterize function well or predict outcomes, although I agree the comparison given its use in public health arenas and clinical risk scores etc. may be warranted. Including the age-PL-SBP interaction, however, is still warranted in my opinion. Again, I may have misunderstood the methods.
Response: We assessed the 3-way (age-PL-SBP) interaction but did not find any evidence that the associations between PL and SBP varied by age category (see response to Comment #3).
9. Please provide more information on spline terms in the Methods (I assume the authors are referring to splines in modeling SBP given the sentence in Results, page 10, line 44. Were clinical categories used or knots decided based on visualization using flexible modeling or on SBP quintile cut points or other?
Response: We used multivariable regression spline models (Stata's mvrs command) to assess the shape of the estimated incidence rates of CVD by quintile of SBP. The MVRS command tests models with varying degrees of freedom for specified variables (from 1 df indicating a linear fit up to 15 df), and presents the model that minimizes AIC. For all results presented in Figure 1 , the association across SBP quintiles was linear. We also added a sentence to the statistical methods section (p. 9) to clarify this approach: "We used multivariable regression spline models to evaluate the best shape (linear or non-linear) of the trend in incidence rate across quintiles."
10. It seems that if the 3-way interaction (PL-SBP-race) is significant, lack of statistical support for the 2-way interaction (PL-SBP) in race stratified models does not mean there is no interaction for a particular race group; rather, sample size and power were likely the reason for lack of statistical significance. Is there any advantage to showing results by race from the overall model containing the 3-way interaction, including estimates with imprecision of those estimates across each race group to make a determination of race differences? Perhaps this was done in the figures already; I don't expect the results would be different but might improve precision of estimates for smaller groups.
Response: We thank the reviewer for this suggestion, and agree that the smaller sample sizes in the Hispanic and Chinese groups may have limited the ability to detect statistically significant differences. However, the fact that the point estimates do not differ qualitatively in the groups with and without limitations in the Poisson models leads us to believe that estimating the results from a single model would not lead to different inference. Additionally, we prefer to use the estimates from the stratified models because that also allows for the coefficients for the covariates to vary by race.
Results

1.
The lowest quintile of SBP may include both healthy and ill (e.g. heart failure) participants given that the lower value is below the normal physiological levels needed to perfuse organs (generally mean arterial pressure over 60-65mmHg). Data entry or measurement errors may also explain the very low SBP number. Do the authors have information on conditions that could cause low BPs?
Response: We think it is unlikely that CHF or other major illness plays a substantial role in those with low SBP. Among those in the lowest quintile (SBP 60-107 mmHg), half had SBP>100 (median 101) and only 10% had SBP<89.5. More information about the characteristics of those in the lowest quintile of SBP are shown below (note that prevalent CHF at exam 2 is low because MESA's eligibility criteria included being free of all cardiovascular disease at baseline, including CHF):
Lowest SBP quintile 2nd -5th quintile Age (mean) 64. 2. Despite the description of linear relationships, some in figure 2 do not appear linear and raises the question of whether sicker participants are in the lower SBP quintile and how the nonlinear relationships were examined.
Response: We agree that some patterns in Figure 1 (we assume the reference to figure 2 was a typo?) do not appear linear, though it is difficult to discern trends due to uncertainty. We ran MVRS models to allow for a non-linear fit in the estimated incidence of CVD across SBP quintiles, but all models indicated that a linear fit was best.
3. Table 2 : When describing lack of modification among Hispanic and Chinese participants or in discussion, it may be worth also highlighting that these groups were a little younger, and Chinese participants had fewer PL and fewer events. Some of this was included by the authors.
Response: we added this to the discussion (p. 14): "We observed no apparent patterning of SBP and CVD by functional status among Hispanics or Chinese participants. For Chinese participants, the small sample size is likely a key limitation for distinguishing patterns by functional status. Additionally, Chinese participants were least likely to report physical limitations and had the lowest incidence of CVD. For Hispanic participants, associations between SBP and CVD were similar by functional status on a multiplicative scale, and on an additive scale appeared to be stronger (larger average IRDs across quintiles of SBP) for those with physical limitations and those at higher ages than those without physical limitations and at lower ages, respectively. Hispanic participants were also the youngest of the racial/ethnic groups in MESA. Previous research in a Hispanic population found that the association between SBP and all-cause mortality was attenuated among slow walkers compared to fast walkers;19 however, these participants were older (mean age 70.5 years) and less healthy overall (mean SBP 139 mmHg, 22.8% on diabetes medication) than MESA's Hispanic participants (mean age 62.7 years, mean SBP 125 mmHg, 16.3% on diabetes medication). Future research should continue to investigate patterns of SBP and CVD risk among diverse minority populations." 4. Figures: consider showing estimates and imprecision around the estimates using confidence bars.
Response: We revised Figure 1 to include confidence bars.
5. I believe Figure 1 shows 'x' and '+' marks as the estimated incidence rates for each SBP quintile by PL strata or selected age with a forced linear regression line across the SBP quintiles. Some of the estimates appear non-linear, specifically for Blacks with physical limitations or older age. Would it be more informative to show the estimates and confidence bars or bands? This would also highlight the smaller samples and greater uncertainty in the smaller groups. Confidence bars or bands could more clearly illustrate that the apparent non-linearities are not supported. The authors included a statement that "Spline models confirmed that a linear fit was appropriate…" although the details of this assessment are not clear to me. Likelihood ratios from comparative models?
Response: We revised Figure 1 to include the confidence bars as described above. We shared the reviewers concern about the potential for non-linear relationships, but the linearity was confirmed by evaluating models with various spline terms, and indeed, the linear model had the best model fit. From page 9 (statistical methods section), "We used multivariable regression spline models to evaluate the best shape (linear or non-linear) of the trend in incidence rate across quintiles. "
6. Figure 1 : per comment #7 in Methods: are these results from analyses that were stratified by race, and included the physical limitations-SBP interaction, SBP, physical limitations and adjusted for age, sex, income (Column 1)? Column 2 is more confusing -are these results modeled using an age-SBP interaction term within race strata, adjusted for sex, income but not adjusted for PL?
Response: Hopefully our revisions to the statistical methods section clarified this. The models in Figure 1 , column 1 were stratified by race and by physical limitations, adjusted for age (continuous), sex, income (dichotomous) and SBP quintiles. The models in column 2 were stratified by race and adjusted for age continuous), sex, income (dichotomous), and SBP quintiles, with incidence rates estimated at the 1st and 3rd quartiles of age (for each quintile of SBP). As described above, we did not find evidence for a SBP-age-PL interaction so we did not further add this 3-way interaction.
7. Page 10, Results, lines 46-53 the authors state "Among white participants, the association between SBP and CVD appeared weaker among those with physical limitations compared to those without physical limitations. However, the average IRD across quintiles of SBP was slightly larger among older whites compared with younger whites." It's not clear if the difference in these numbers, 3.6 vs 2.99 per 10,000 py, is really meaningful; how was the difference in the magnitude of these estimates quantified? In addition, does this suggest the effect of increasing SBP is greater at older than younger ages, perhaps because older people are more likely to have events? Where does PL fit into this interpretation?
Response: We agree that 3.6 vs 2.99 per 1000 py may not be a meaningful difference -our goal was to highlight that among whites, the age interaction appears synergistic on an additive scale, instead of antagonistic as on the multiplicative scale. We have restated as: "Among white participants, the estimated increase in CVD per quintile higher SBP was smaller for those with physical limitations than for those without physical limitations. However, the average IRD across quintiles of SBP was slightly larger among older whites (estimated at age 70) compared with younger whites (estimated at age 54). " (p. 10)
8. Response: We have made this change.
11. Recommend either including DBP results in online supplement or leave this out.
Response: we removed references to our analysis using DBP. Discussion 1. The authors are appropriately cautious in interpreting results, specifically identifying the limitation of fewer numbers of Hispanics and Chinese participants compared to whites and blacks. In MESA, relationships among blacks and whites appear similar, in line with our findings from middle-aged and older adults in the ARIC population. Given these similar findings in two large studies with blacks and whites (but small representation of other race/ethnicity groups in MESA and no representation in ARIC), perhaps the discussion should be more assertive regarding the limitations in drawing conclusions about lack of findings among Hispanic and Chinese populations. I am not certain, for example, that the findings "show distinct racial/ethnic patterning". However, the findings do suggest that functional limitations may portend elevated risk in all examined racial/ethnic groups in MESA. Understanding how functional status (or factors underlying functional impairments) influence CV risk across racial/ethnic groups could be useful for identifying at-risk persons and informing public health strategies to improve health and reduce CV risk.
Response: We revised the end of the 2nd paragraph in the discussion to clarify the importance of functional limitations: "Additionally, across all race/ethnic groups, those with physical limitations had higher incidence of CVD at all levels of SBP than those without physical limitations, after adjusting for age. Where feasible, self-reported physical limitations or other specific measures of functional status may be a useful addition to methods of assessing risk in clinical settings." We also revised the last paragraph of the discussion to emphasize the limited sample size for Hispanic and Chinese populations: "In summary, we found that the risk of incident CVD associated with high blood pressure appears to be attenuated among white and black adults with physical limitations and at older ages in a diverse cohort of middle aged and older adults. Patterns among Hispanic and Chinese adults were less clear, which likely reflects limited sample sizes. Understanding how functional status (or factors underlying functional impairments) influence CVD risk across racial/ethnic groups could be useful for identifying at-risk persons and informing public health strategies to improve health and reduce CVD risk."
2. I don't understand why the authors make the statement "This pattern appeared to be consistent across both multiplicative and additive scales using self-reported physical limitations, but not age" in Discussion, 1st paragraph, and again in Discussion, 2nd paragraph "Among white participants, using self-reported physical limitations as a measure of functional status provided consistent evidence of attenuated associations between SBP and incident CVD across multiplicative and additive scales, while chronological age did not. Where feasible, physical limitations and other specific measures of functional status may be more useful than chronological age in estimating risk". a. First, are the recommendations specific to whites? This runs counter to the rationale of the study which is a focus on various racial/ethnic groups. b. Table 2 shows interactions between PL and SBP supported in whites but not blacks although blacks had similar estimates that were not statistically supported with conventional metrics, and interactions between age and SBP were supported in both whites and blacks. Thus, PL may not work as well in blacks as in whites, yet the authors propose using PL instead of age. c. For the additive models, is the statement that age does not work as well based on the magnitude of IRDs by age in Figure 2 , which were not as large as in the PL analysis? Please clarify.
Response: The reviewer is correct that this statement was based on the consistent finding of an attenuated effect of SBP among those with PL on both scales, whereas the effect modification for age appears stronger in the multiplicative models. We observed this for white participants, but not Hispanic or Chinese. In black participants, PL and age were both consistent on both scales in revealing attenuated effects of SBP (though not statistically significant for PL on a multiplicative scale. We have clarified to the following (p. 13-14): "Among white participants, using self-reported physical limitations as a measure of functional status provided consistent evidence of attenuated associations between SBP and incident CVD among adults with physical limitations across multiplicative and additive scales, while there was not an attenuated association between SBP and incident CVD among older adults on an additive scale.
Among blacks, both older age and physical limitations revealed attenuated associations between SBP and CVD on both multiplicative and additive scales (though not statistically significant for physical limitations on a multiplicative scale). Additionally, across all race/ethnic groups, those with physical limitations had higher incidence of CVD at all levels of SBP than those without physical limitations, after adjusting for age. Where feasible, self-reported physical limitations or other specific measures of functional status may be a useful addition to methods of assessing risk in clinical settings."
3. In discussing the associations between SBP and CVD by functional status, perhaps use less using methodological jargon (multiplicative and additive scales) and more context of how clinicians or researchers would use this information.
Response: We agree, and rephrased where appropriate. We did retain discussion of multiplicative and additive scales since this is so crucial for accurate evaluation of an interaction. Since an elevated baseline risk (such as in those who are older or have physical limitation) can attenuate a relative risk, but not a risk difference, we wish to highlight consistencies and differences in multiplicative and additive models. We agree that this language might be challenging for clinicians, but we think it is important to highlight this methodologic issue.
Reviewer #2
1. Page 2, lines 26-33. Please use the terms consistently. In this paragraph "low functional status" refers only to physical limitations, as only IRR for these groups are presented; whereas in other sections "low functional status" includes chronological age (page 9, lines 13-14). The statement starting on line 30 "We found a similar pattern …" doesn't reflect the results of physical limitations in Table 2 .
Response: We revised the results section of the abstract to read, "We observed weaker associations between systolic blood pressure and cardiovascular disease among white adults with physical limitations (IRR per 10-mmHg higher systolic blood pressure: 
